The Potential Cardioprotective Effect of Addition of Atorvastatin in Breast Cancer Patients | MicrobiomeTrials← Back to trialsNCT07668076
The Potential Cardioprotective Effect of Addition of Atorvastatin in Breast Cancer Patients
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2022-11-15Est. Completion: 2024-10-20
Enrollment target: 44 participants Locations- Damanhour university, Beheira, Damanhour, Egypt
Other microbiome trials you might be interested in
Locally Advanced Hypopharyngeal Squamous Cell CarcinomaLocally Advanced Laryngeal Squamous Cell CarcinomaLocally Advanced Oral Cavity Squamous Cell CarcinomaLocally Advanced Oropharyngeal Squamous Cell Carcinoma
This phase III trial compares cetuximab to chemotherapy, carboplatin and paclitaxel, with intensity modulated radiation …
Birmingham, United StatesEst. completion Nov 30, 2035
Breast Cancer
The purpose of this study is to find out whether electronic tools that provide information and reminders to people at hi…
New York, United StatesEst. completion Sep 2028
Non-small Cell Lung CancerNSCLC
This is a phase 3 study of pembrolizumab in combination with carboplatin/taxane (paclitaxel or nab-paclitaxel) followed …
Little Rock, United StatesEst. completion Jan 12, 2029